{"data":[{"accessionNo":"0001214659-26-012924","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001516551","issuerName":"Skye Bioscience, Inc.","ticker":"SKYE","cusip":"83086J309","securityClass":"Common Stock, par value $0.001","eventDate":"2026-10-07","reportingPerson":"TANG CAPITAL MANAGEMENT, LLC","reportingCik":null,"personType":"OO","sharesOwned":263560,"percentOfClass":6,"filedAt":"2026-10-14","canonicalUrl":"https://xoomar.com/markets/stocks/skye"},{"accessionNo":"0001214659-26-012924","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001516551","issuerName":"Skye Bioscience, Inc.","ticker":"SKYE","cusip":"83086J309","securityClass":"Common Stock, par value $0.001","eventDate":"2026-10-07","reportingPerson":"KEVIN TANG","reportingCik":null,"personType":"IN","sharesOwned":263560,"percentOfClass":6,"filedAt":"2026-10-14","canonicalUrl":"https://xoomar.com/markets/stocks/skye"},{"accessionNo":"0001214659-26-012924","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001516551","issuerName":"Skye Bioscience, Inc.","ticker":"SKYE","cusip":"83086J309","securityClass":"Common Stock, par value $0.001","eventDate":"2026-10-07","reportingPerson":"TANG CAPITAL PARTNERS INTERNATIONAL, LP","reportingCik":null,"personType":"PN","sharesOwned":83556,"percentOfClass":1.8,"filedAt":"2026-10-14","canonicalUrl":"https://xoomar.com/markets/stocks/skye"},{"accessionNo":"0001214659-26-012924","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001516551","issuerName":"Skye Bioscience, Inc.","ticker":"SKYE","cusip":"83086J309","securityClass":"Common Stock, par value $0.001","eventDate":"2026-10-07","reportingPerson":"TANG CAPITAL PARTNERS IV, INC","reportingCik":null,"personType":"CO","sharesOwned":60002,"percentOfClass":1.4,"filedAt":"2026-10-14","canonicalUrl":"https://xoomar.com/markets/stocks/skye"},{"accessionNo":"0001214659-26-012924","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001516551","issuerName":"Skye Bioscience, Inc.","ticker":"SKYE","cusip":"83086J309","securityClass":"Common Stock, par value $0.001","eventDate":"2026-10-07","reportingPerson":"TANG CAPITAL PARTNERS, LP","reportingCik":null,"personType":"PN","sharesOwned":60000,"percentOfClass":1.4,"filedAt":"2026-10-14","canonicalUrl":"https://xoomar.com/markets/stocks/skye"},{"accessionNo":"0001214659-26-012924","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001516551","issuerName":"Skye Bioscience, Inc.","ticker":"SKYE","cusip":"83086J309","securityClass":"Common Stock, par value $0.001","eventDate":"2026-10-07","reportingPerson":"TANG CAPITAL PARTNERS III, INC","reportingCik":null,"personType":"CO","sharesOwned":60002,"percentOfClass":1.4,"filedAt":"2026-10-14","canonicalUrl":"https://xoomar.com/markets/stocks/skye"},{"accessionNo":"0001873545-26-000009","formType":"SCHEDULE 13D/A","amendmentNo":6,"issuerCik":"0001516551","issuerName":"SKYE BIOSCIENCE, INC.","ticker":"SKYE","cusip":"83086J309","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-09-22","reportingPerson":"Andrew J. Schwab","reportingCik":"0001598549","personType":"IN","sharesOwned":1218088,"percentOfClass":26.1,"filedAt":"2026-09-24","canonicalUrl":"https://xoomar.com/markets/stocks/skye"},{"accessionNo":"0001873545-26-000009","formType":"SCHEDULE 13D/A","amendmentNo":6,"issuerCik":"0001516551","issuerName":"SKYE BIOSCIENCE, INC.","ticker":"SKYE","cusip":"83086J309","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-09-22","reportingPerson":"Kush Parmar","reportingCik":"0001664281","personType":"IN","sharesOwned":1194443,"percentOfClass":25.7,"filedAt":"2026-09-24","canonicalUrl":"https://xoomar.com/markets/stocks/skye"},{"accessionNo":"0001873545-26-000009","formType":"SCHEDULE 13D/A","amendmentNo":6,"issuerCik":"0001516551","issuerName":"SKYE BIOSCIENCE, INC.","ticker":"SKYE","cusip":"83086J309","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-09-22","reportingPerson":"5AM Ventures VII, L.P.","reportingCik":"0001844435","personType":"PN","sharesOwned":1194443,"percentOfClass":25.7,"filedAt":"2026-09-24","canonicalUrl":"https://xoomar.com/markets/stocks/skye"},{"accessionNo":"0001873545-26-000009","formType":"SCHEDULE 13D/A","amendmentNo":6,"issuerCik":"0001516551","issuerName":"SKYE BIOSCIENCE, INC.","ticker":"SKYE","cusip":"83086J309","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-09-22","reportingPerson":"5AM Partners VII, LLC","reportingCik":"0001873545","personType":"OO","sharesOwned":1194443,"percentOfClass":25.7,"filedAt":"2026-09-24","canonicalUrl":"https://xoomar.com/markets/stocks/skye"},{"accessionNo":"0001873545-26-000009","formType":"SCHEDULE 13D/A","amendmentNo":6,"issuerCik":"0001516551","issuerName":"SKYE BIOSCIENCE, INC.","ticker":"SKYE","cusip":"83086J309","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-09-22","reportingPerson":"5AM Partners II, LLC","reportingCik":"0001555952","personType":"OO","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-09-24","canonicalUrl":"https://xoomar.com/markets/stocks/skye"},{"accessionNo":"0001873545-26-000009","formType":"SCHEDULE 13D/A","amendmentNo":6,"issuerCik":"0001516551","issuerName":"SKYE BIOSCIENCE, INC.","ticker":"SKYE","cusip":"83086J309","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-09-22","reportingPerson":"Scott M. Rocklage","reportingCik":"0001219014","personType":"IN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-09-24","canonicalUrl":"https://xoomar.com/markets/stocks/skye"},{"accessionNo":"0001873545-26-000009","formType":"SCHEDULE 13D/A","amendmentNo":6,"issuerCik":"0001516551","issuerName":"SKYE BIOSCIENCE, INC.","ticker":"SKYE","cusip":"83086J309","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-09-22","reportingPerson":"John D. Diekman","reportingCik":"0001240357","personType":"IN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-09-24","canonicalUrl":"https://xoomar.com/markets/stocks/skye"},{"accessionNo":"0001873545-26-000009","formType":"SCHEDULE 13D/A","amendmentNo":6,"issuerCik":"0001516551","issuerName":"SKYE BIOSCIENCE, INC.","ticker":"SKYE","cusip":"83086J309","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-09-22","reportingPerson":"5AM Co-Investors II, L.P.","reportingCik":"0001390376","personType":"PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-09-24","canonicalUrl":"https://xoomar.com/markets/stocks/skye"},{"accessionNo":"0001873545-26-000009","formType":"SCHEDULE 13D/A","amendmentNo":6,"issuerCik":"0001516551","issuerName":"SKYE BIOSCIENCE, INC.","ticker":"SKYE","cusip":"83086J309","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-09-22","reportingPerson":"5AM Ventures II, L.P.","reportingCik":"0001386509","personType":"PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-09-24","canonicalUrl":"https://xoomar.com/markets/stocks/skye"},{"accessionNo":"0001873545-26-000007","formType":"SCHEDULE 13D/A","amendmentNo":5,"issuerCik":"0001516551","issuerName":"SKYE BIOSCIENCE, INC.","ticker":"SKYE","cusip":"83086J200","securityClass":"Common Stock, par value $0.001","eventDate":"2026-08-14","reportingPerson":"Andrew J. Schwab","reportingCik":"0001598549","personType":"IN","sharesOwned":11273407,"percentOfClass":30.2,"filedAt":"2026-08-18","canonicalUrl":"https://xoomar.com/markets/stocks/skye"},{"accessionNo":"0001873545-26-000007","formType":"SCHEDULE 13D/A","amendmentNo":5,"issuerCik":"0001516551","issuerName":"SKYE BIOSCIENCE, INC.","ticker":"SKYE","cusip":"83086J200","securityClass":"Common Stock, par value $0.001","eventDate":"2026-08-14","reportingPerson":"5AM Ventures VII, L.P.","reportingCik":"0001844435","personType":"PN","sharesOwned":9619519,"percentOfClass":25.9,"filedAt":"2026-08-18","canonicalUrl":"https://xoomar.com/markets/stocks/skye"},{"accessionNo":"0001873545-26-000007","formType":"SCHEDULE 13D/A","amendmentNo":5,"issuerCik":"0001516551","issuerName":"SKYE BIOSCIENCE, INC.","ticker":"SKYE","cusip":"83086J200","securityClass":"Common Stock, par value $0.001","eventDate":"2026-08-14","reportingPerson":"5AM Partners VII, LLC","reportingCik":"0001873545","personType":"OO","sharesOwned":9619519,"percentOfClass":25.9,"filedAt":"2026-08-18","canonicalUrl":"https://xoomar.com/markets/stocks/skye"},{"accessionNo":"0001873545-26-000007","formType":"SCHEDULE 13D/A","amendmentNo":5,"issuerCik":"0001516551","issuerName":"SKYE BIOSCIENCE, INC.","ticker":"SKYE","cusip":"83086J200","securityClass":"Common Stock, par value $0.001","eventDate":"2026-08-14","reportingPerson":"Kush Parmar","reportingCik":"0001664281","personType":"IN","sharesOwned":9619519,"percentOfClass":25.9,"filedAt":"2026-08-18","canonicalUrl":"https://xoomar.com/markets/stocks/skye"},{"accessionNo":"0001873545-26-000007","formType":"SCHEDULE 13D/A","amendmentNo":5,"issuerCik":"0001516551","issuerName":"SKYE BIOSCIENCE, INC.","ticker":"SKYE","cusip":"83086J200","securityClass":"Common Stock, par value $0.001","eventDate":"2026-08-14","reportingPerson":"Scott M. Rocklage","reportingCik":"0001219014","personType":"IN","sharesOwned":1467637,"percentOfClass":4.1,"filedAt":"2026-08-18","canonicalUrl":"https://xoomar.com/markets/stocks/skye"},{"accessionNo":"0001873545-26-000007","formType":"SCHEDULE 13D/A","amendmentNo":5,"issuerCik":"0001516551","issuerName":"SKYE BIOSCIENCE, INC.","ticker":"SKYE","cusip":"83086J200","securityClass":"Common Stock, par value $0.001","eventDate":"2026-08-14","reportingPerson":"5AM Partners II, LLC","reportingCik":"0001555952","personType":"OO","sharesOwned":1467637,"percentOfClass":4.1,"filedAt":"2026-08-18","canonicalUrl":"https://xoomar.com/markets/stocks/skye"},{"accessionNo":"0001873545-26-000007","formType":"SCHEDULE 13D/A","amendmentNo":5,"issuerCik":"0001516551","issuerName":"SKYE BIOSCIENCE, INC.","ticker":"SKYE","cusip":"83086J200","securityClass":"Common Stock, par value $0.001","eventDate":"2026-08-14","reportingPerson":"John D. Diekman","reportingCik":"0001240357","personType":"IN","sharesOwned":1467637,"percentOfClass":4.1,"filedAt":"2026-08-18","canonicalUrl":"https://xoomar.com/markets/stocks/skye"},{"accessionNo":"0001873545-26-000007","formType":"SCHEDULE 13D/A","amendmentNo":5,"issuerCik":"0001516551","issuerName":"SKYE BIOSCIENCE, INC.","ticker":"SKYE","cusip":"83086J200","securityClass":"Common Stock, par value $0.001","eventDate":"2026-08-14","reportingPerson":"5AM Ventures II, L.P.","reportingCik":"0001386509","personType":"PN","sharesOwned":1411974,"percentOfClass":4,"filedAt":"2026-08-18","canonicalUrl":"https://xoomar.com/markets/stocks/skye"},{"accessionNo":"0001873545-26-000007","formType":"SCHEDULE 13D/A","amendmentNo":5,"issuerCik":"0001516551","issuerName":"SKYE BIOSCIENCE, INC.","ticker":"SKYE","cusip":"83086J200","securityClass":"Common Stock, par value $0.001","eventDate":"2026-08-14","reportingPerson":"5AM Co-Investors II, L.P.","reportingCik":"0001390376","personType":"PN","sharesOwned":55663,"percentOfClass":0.2,"filedAt":"2026-08-18","canonicalUrl":"https://xoomar.com/markets/stocks/skye"},{"accessionNo":"0001873545-25-000004","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001516551","issuerName":"SKYE BIOSCIENCE, INC.","ticker":"SKYE","cusip":null,"securityClass":"Common Stock, par value $0.001","eventDate":"2025-12-12","reportingPerson":"Andrew J. Schwab","reportingCik":"0001598549","personType":"IN","sharesOwned":11541317,"percentOfClass":34,"filedAt":"2025-12-16","canonicalUrl":"https://xoomar.com/markets/stocks/skye"},{"accessionNo":"0001873545-25-000004","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001516551","issuerName":"SKYE BIOSCIENCE, INC.","ticker":"SKYE","cusip":null,"securityClass":"Common Stock, par value $0.001","eventDate":"2025-12-12","reportingPerson":"Kush Parmar","reportingCik":"0001664281","personType":"IN","sharesOwned":9872599,"percentOfClass":29.2,"filedAt":"2025-12-16","canonicalUrl":"https://xoomar.com/markets/stocks/skye"},{"accessionNo":"0001873545-25-000004","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001516551","issuerName":"SKYE BIOSCIENCE, INC.","ticker":"SKYE","cusip":null,"securityClass":"Common Stock, par value $0.001","eventDate":"2025-12-12","reportingPerson":"5AM Ventures VII, L.P.","reportingCik":"0001844435","personType":"PN","sharesOwned":9872599,"percentOfClass":29.2,"filedAt":"2025-12-16","canonicalUrl":"https://xoomar.com/markets/stocks/skye"},{"accessionNo":"0001873545-25-000004","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001516551","issuerName":"SKYE BIOSCIENCE, INC.","ticker":"SKYE","cusip":null,"securityClass":"Common Stock, par value $0.001","eventDate":"2025-12-12","reportingPerson":"5AM Partners VII, LLC","reportingCik":"0001873545","personType":"OO","sharesOwned":9872599,"percentOfClass":29.2,"filedAt":"2025-12-16","canonicalUrl":"https://xoomar.com/markets/stocks/skye"},{"accessionNo":"0001873545-25-000004","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001516551","issuerName":"SKYE BIOSCIENCE, INC.","ticker":"SKYE","cusip":null,"securityClass":"Common Stock, par value $0.001","eventDate":"2025-12-12","reportingPerson":"Scott M. Rocklage","reportingCik":"0001219014","personType":"IN","sharesOwned":1514557,"percentOfClass":4.7,"filedAt":"2025-12-16","canonicalUrl":"https://xoomar.com/markets/stocks/skye"},{"accessionNo":"0001873545-25-000004","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001516551","issuerName":"SKYE BIOSCIENCE, INC.","ticker":"SKYE","cusip":null,"securityClass":"Common Stock, par value $0.001","eventDate":"2025-12-12","reportingPerson":"5AM Partners II, LLC","reportingCik":"0001555952","personType":"OO","sharesOwned":1514557,"percentOfClass":4.7,"filedAt":"2025-12-16","canonicalUrl":"https://xoomar.com/markets/stocks/skye"},{"accessionNo":"0001873545-25-000004","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001516551","issuerName":"SKYE BIOSCIENCE, INC.","ticker":"SKYE","cusip":null,"securityClass":"Common Stock, par value $0.001","eventDate":"2025-12-12","reportingPerson":"John D. Diekman","reportingCik":"0001240357","personType":"IN","sharesOwned":1514557,"percentOfClass":4.7,"filedAt":"2025-12-16","canonicalUrl":"https://xoomar.com/markets/stocks/skye"},{"accessionNo":"0001873545-25-000004","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001516551","issuerName":"SKYE BIOSCIENCE, INC.","ticker":"SKYE","cusip":null,"securityClass":"Common Stock, par value $0.001","eventDate":"2025-12-12","reportingPerson":"5AM Ventures II, L.P.","reportingCik":"0001386509","personType":"PN","sharesOwned":1457064,"percentOfClass":4.5,"filedAt":"2025-12-16","canonicalUrl":"https://xoomar.com/markets/stocks/skye"},{"accessionNo":"0001873545-25-000004","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001516551","issuerName":"SKYE BIOSCIENCE, INC.","ticker":"SKYE","cusip":null,"securityClass":"Common Stock, par value $0.001","eventDate":"2025-12-12","reportingPerson":"5AM Co-Investors II, L.P.","reportingCik":"0001390376","personType":"PN","sharesOwned":57493,"percentOfClass":0.2,"filedAt":"2025-12-16","canonicalUrl":"https://xoomar.com/markets/stocks/skye"}],"updatedAt":"2026-11-04T00:46:06.912Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/skye","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}